York scientists one step closer to finding a new generation of antibiotics
16 October 2015 | By Victoria White
The scientists used novel genetic engineering tools to manipulate the genes required for antibiotic biosynthesis...
List view / Grid view
News
Researchers describe new molecular markers for high-risk neuroblastoma
16 October 2015 | By Victoria White
Researchers have identified previously unknown genomic alterations leading to up-regulation of the telomerase reverse transcriptase gene (TERT). Overexpression of TERT is often associated with cancers and tumour formation...
Breast cancer vaccine OQR200 completes proof-of-concept study
15 October 2015 | By Victoria White
In the study, the vaccine elicited the expression of very high levels of polyclonal antibodies targeting multiple epitopes on Her2/neu...
Ablynx’s nanobody construct achieves proof-of-concept in tumour model
15 October 2015 | By Victoria White
The nanobody construct binds to two different immune modulators, proteins believed to be targets for the development of important cancer immunotherapies...
OICR, Novera and Janssen to develop haematological cancer therapies
15 October 2015 | By Victoria White
As part of the collaboration, Novera will discover and develop novel therapeutic compounds identified through OICR's drug discovery programme...
GPR3 identified as a new target for Alzheimer’s disease treatment
15 October 2015 | By Victoria White
Researchers have determined that the protein GPR3 might play an important role in alleviating the cognitive deficits of 'amyloid plaques'...
Gene therapy shows promise in retinitis pigmentosa
14 October 2015 | By Victoria White
Research has shown that gene therapy preserved vision in a study involving dogs with naturally occurring, late-stage retinitis pigmentosa...
Minoryx to validate MIN-102 with Series A funding
14 October 2015 | By Victoria White
A Series A funding round of €19.4M will see Minoryx Therapeutics move its lead project MIN-102 to clinical validation for X-linked adrenoleukodystrophy (X-ALD)...
UCL and Takeda to identify targets for neurodegenerative diseases
14 October 2015 | By Victoria White
The three-year collaboration will focus on mechanistic approaches for the identification of genes or signalling pathways that modify neurodegenerative disease processes affecting neuronal health...
Researchers develop animal-free renal screening platform
13 October 2015 | By Victoria White
Researchers have developed the first animal-free screening platforms capable of predicting the toxic effects of compounds on the human kidney accurately...
Malaria vaccine provides hope for a cure for cancer
13 October 2015 | By Victoria White
Scientists have created a malaria protein with a toxin seeks out cancer cells. The protein is absorbed, the toxin released inside, and then the cancer cells die...
Lilly and ImaginAb to investigate imaging agent in immuno-oncology therapies
13 October 2015 | By Victoria White
ImaginAb will conduct preclinical research using its immune imaging agent, IAB22M2C, to detect T-cell trafficking, redirection and infiltration in response to Lilly oncology molecules...
Exon skipping demonstrates success in severe form of muscular dystrophy
13 October 2015 | By Victoria White
An RNA editing technique called "exon skipping" has demonstrated preliminary success in treating Limb Girdle Muscular Dystrophy Type 2C in a new study...
Tamoxifen beats MRSA superbug in mice models
13 October 2015 | By Victoria White
Researchers have found that tamoxifen gives white blood cells a boost, better enabling them to respond to and kill bacteria in laboratory experiments...
Asterias collaborates with Cell Therapy Catapult to scale production of AST-VAC2
13 October 2015 | By Victoria White
AST-VAC2 is an immunotherapy product that contains mature dendritic cells derived from pluripotent stem cells...
